{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:38Z","timestamp":1792108838819,"version":"4.4.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Sertoli\u2013Leydig cell tumors (SLCTs) are rare, with a challenging diagnosis and management. Herein is our case.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report:<\/jats:title>\n                    <jats:p>We report the case of a 14-year-old female patient who presented with secondary amenorrhea with clinical signs of virilization. A pelvic MRI showed a solid-cystic intraperitoneal mass. The patient underwent surgery. A left adnexectomy, along with an omentectomy, peritoneal biopsy, and peritoneal cytology sampling, was performed. The histopathological examination confirmed a Sertoli-Leydig cell tumor of the left ovary. While the majority of the tumor cells were well-differentiated, a focal area contained poorly differentiated cells with high mitotic activity and sarcoma-like features. The case was presented at a multidisciplinary tumor board meeting to assess the potential benefit of adjuvant chemotherapy, given the presence of a poorly differentiated component. However, adjuvant chemotherapy was not recommended.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>SLCTs are rare ovarian neoplasms that predominantly affect individuals of reproductive age. Virilization occurs in up to 60 % of cases. Serum tumor markers can aid in the detection of SLCTs. According to the latest WHO classification, SLCTs are categorized as well-differentiated, moderately differentiated, or poorly differentiated. Surgical resection remains the gold standard treatment, while postoperative chemotherapy is recommended for patients with poor prognostic factors. However, managing SLCTs remains challenging due to the lack of standardized treatment guidelines. Prognosis is primarily determined by tumor stage and degree of differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Managing SLCTs remains complex, and further studies are needed to better define treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2025.111565","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:02:48Z","timestamp":1750644168000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Sertoli-Leydig cell tumor: An unusual pathological presentation raising a therapeutic dilemma, a case report"],"prefix":"10.1097","volume":"133","author":[{"given":"Eya","family":"Rahmouni","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montassar","family":"Ghalleb","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Amine","family":"Bouida","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoldez","family":"Houcine","sequence":"additional","affiliation":[{"name":"Pathology department, Salah Azaiez Institute, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Slimane","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Ben","family":"Dhiab","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-64-20260310","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2012.07.114","article-title":"A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors","volume":"127","author":"Gui","year":"2012","journal-title":"Gynecol. Oncol"},{"issue":"1","key":"R2-64-20260310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0973-1482.158037","article-title":"Ovarian sertoli-leydig cell tumors: a multicenter long-term clinicopathological analysis of 27 patients","volume":"12","author":"Akman","year":"2016","journal-title":"J. Cancer Res. Ther"},{"issue":"1","key":"R3-64-20260310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/ijabmr.IJABMR_84_18","article-title":"Sertoli-Leydig cell tumor of ovary: a rare case report with heterologous elements and focal marked anaplasia","volume":"9","author":"Gautam","year":"2019","journal-title":"Int. J. Appl. Basic Med. Res"},{"issue":"3","key":"R5-64-20260310","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/IJPM.IJPM_443_20","article-title":"Sertoli-Leydig cell tumor of ovary in children: a report of two cases, including retiform variant","volume":"64","author":"Sarkar","year":"2021","journal-title":"Indian J. Pathol. Microbiol"},{"issue":"12","key":"R6-64-20260310","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.5858\/arpa.2018-0291-RA","article-title":"Ovarian sex cord-stromal tumors: reflections on a 40-year experience with a fascinating group of tumors, including comments on the seminal observations of Robert E. Scully, MD","volume":"142","author":"Young","year":"2018","journal-title":"Arch. Pathol. Lab Med"},{"issue":"9","key":"R7-64-20260310","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw"},{"issue":"3","key":"R8-64-20260310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13193-019-00928-3","article-title":"Ovarian Sertoli-Leydig cell tumor with estrogenic manifestations in a postmenopausal lady: a case report","volume":"10","author":"Priyadarshini","year":"2019","journal-title":"Indian J. Surg. Oncol"},{"issue":"9","key":"R9-64-20260310","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091845","article-title":"Spectrum of DICER1 germline pathogenic variants in ovarian Sertoli-Leydig cell tumor","volume":"10","author":"De Paolis","year":"2021","journal-title":"J. Clin. Med"},{"issue":"5","key":"R10-64-20260310","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1210\/clinem\/dgac673","article-title":"Approach to investigation of hyperandrogenism in a postmenopausal woman","volume":"108","author":"Hirschberg","year":"2023","journal-title":"J. Clin. Endocrinol. Metab"},{"issue":"181","key":"R11-64-20260310","doi-asserted-by":"crossref","first-page":"234","DOI":"10.24976\/Discov.Med.202436181.22","article-title":"Review on Sertoli-Leydig cell tumours of the ovary","volume":"36","author":"Muscat","year":"2024","journal-title":"Discov. Med"},{"issue":"Supplement_1","key":"R12-64-20260310","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa046.011","article-title":"SUN-002 hormonal profile of ovarian Sertoli-Leydig cell tumor","volume":"4","author":"Torchinsky","year":"2020","journal-title":"J. Endocr. Soc"},{"issue":"42","key":"R13-64-20260310","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012865","article-title":"Sertoli-Leydig cell tumors of ovary: a case series","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R14-64-20260310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2023.108043","article-title":"Ovarian Sertoli-Leydig tumor: a tricky tumor case report","volume":"105","author":"Khalloufi","year":"2023","journal-title":"Int. J. Surg. Case Rep"},{"issue":"2","key":"R15-64-20260310","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00404-020-05633-z","article-title":"Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes","volume":"302","author":"Nasioudis","year":"2020","journal-title":"Arch. Gynecol. Obstet"},{"issue":"5","key":"R16-64-20260310","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1634\/theoncologist.2017-0632","article-title":"Results from a monocentric long-term analysis of 23 patients with ovarian Sertoli-Leydig cell tumors","volume":"24","author":"Gouy","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"R17-64-20260310","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ygyno.2012.03.024","article-title":"Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study","volume":"125","author":"Sigismondi","year":"2012","journal-title":"Gynecol. Oncol"},{"key":"R18-64-20260310","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejogrb.2021.06.036","article-title":"Ovarian Sertoli-Leydig cell tumours: a systematic review of relapsed cases","volume":"263","author":"Nef","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225007515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225007515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2025.111565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:06:28Z","timestamp":1773137188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2025.111565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":17,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2025.111565","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"2025-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}